14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

CHMA Predictions History

2 years ago
JS predicted that CHMA for 2021-05-24 is going $4.22 (-1.17%)

3 years ago
JS predicted that CHMA for 2021-03-24 is going $3.54 (17.22%)

3 years ago
josephr209 predicted that CHMA for 2021-03-08 is going $2.98 (0.00%)

Rank:

4 years ago
JS predicted that CHMA for 2020-04-20 is going $4.59 (1.55%)

4 years ago
2poJeff predicted that CHMA for 2020-04-20 is going $4.45 (-1.77%)

4 years ago
تراحيب العتيبي predicted that CHMA for 2020-04-20 is going

Rank:

4 years ago
NameNotImportant predicted that CHMA for 2019-05-02 is going $5.54 (-6.58%)

5 years ago
NameNotImportant predicted that CHMA for 2019-04-24 is going $5.95 (-0.50%)

6 years ago
Luxbu predicted that CHMA for 2018-03-16 is going $1.52 (-7.88%)

Rank:

7 years ago
JS predicted that CHMA for 2016-11-01 is going $2.30 (9.52%)

Click to get the best stock tips daily for free!

About Chiasma

Chiasma Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massa... CHMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT